Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
1(5%)
Results Posted
33%(3 trials)
Terminated
2(10%)

Phase Distribution

Ph not_applicable
10
50%
Ph phase_1
2
10%
Ph phase_4
6
30%
Ph phase_2
2
10%

Phase Distribution

2

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
2(10.0%)
Phase 2Efficacy & side effects
2(10.0%)
Phase 4Post-market surveillance
6(30.0%)
N/ANon-phased studies
10(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

20

all time

Status Distribution
Active(3)
Completed(9)
Terminated(2)
Other(6)

Detailed Status

Completed9
unknown6
Terminated2
Recruiting1
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
1
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (10.0%)
Phase 22 (10.0%)
Phase 46 (30.0%)
N/A10 (50.0%)

Trials by Status

recruiting15%
terminated210%
enrolling_by_invitation15%
completed945%
unknown630%
not_yet_recruiting15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07242703Not Applicable

Efficacy of Ultraviolet B Phototherapy in the Management of Resistant and Relapsing Tinea Corporis and Tinea Cruris

Not Yet Recruiting
NCT06593197Phase 4

Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients

Enrolling By Invitation
NCT03020199Phase 4

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

Completed
NCT06712238Not Applicable

Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients

Recruiting
NCT04811326Phase 4

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

Unknown
NCT05647187Not Applicable

Effect Narrow-Band UVB Radiations

Completed
NCT00622180Not Applicable

The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands

Completed
NCT04071106Phase 2

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

Unknown
NCT03526705Not Applicable

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

Unknown
NCT03831269Not Applicable

Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin

Unknown
NCT03199664Phase 4

Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo

Unknown
NCT03160053Not Applicable

Improving Keloids Using Targeted Ultraviolet-B Irradiation

Completed
NCT03234673Phase 1

The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

Unknown
NCT02275650Not Applicable

The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter

Completed
NCT01402414Not Applicable

Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis

Terminated
NCT00110981Phase 4

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

Completed
NCT01382589Phase 2

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo

Completed
NCT00640393Phase 4

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

Completed
NCT00844363Not Applicable

Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris

Terminated
NCT00050661Phase 1

To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris

Completed

All 20 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
20